Search results
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 3 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
New lung cancer pill could ‘stop disease in its tracks’
Daily Telegraph· 5 days agoPatients with an incurable form of lung cancer could lead normal lives by taking a daily pill that...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 1 day agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
Rep. Sheila Jackson Lee reveals she's been diagnosed with pancreatic cancer. Here's what to know...
Yahoo Life· 2 days agoCancer Society's latest data. And it’s on track to become the second-leading cause of cancer death...
AstraZeneca Buy rating, stock target reiterated on consistent presence By Investing.com
Investing.com· 6 hours agoThe company's trials include AVANZAR, evaluating Dato-DXd plus Imfinzi for first-line treatment of...
National Cancer Survivors Day: Celebrating Strength, Inspiring Hope, And Highlighting Advances In ...
Black Enterprise· 3 days agoJune 2 is National Cancer Survivors Day (NCSD). The day is a poignant reminder of the progress made...
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 6 days agoIt is now being trialled in people for whom standard treatments, such as chemotherapy, have not...
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors...
The Woonsocket Call· 4 days agoOlomorasib is an investigational, oral, potent, and highly selective second-generation inhibitor of the KRAS G12C protein.
Pfizer's drug for advanced lung cancer shows promising long-term trial results
CNBC· 5 days agoPfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 2 days agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with ...